AVXL Earnings ANAVEX LIFE SCIENCES CORP.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Net income
ROE
Quarterly results
EPS
Net income
ROE
Reported EPS history
1–44 of 44
| Q3 2026 | 2026-06-30 | -0.03 | 2026-08-28 | 10-Q |
| Q2 2026 | 2026-03-31 | -0.12 | 2026-08-28 | 10-Q |
| Q1 2026 | 2025-12-31 | -0.06 | 2026-02-09 | 10-Q |
| FY 2025 | 2025-09-30 | -0.54 | 2025-11-25 | 10-K |
| Q3 2026 | 2025-06-30 | -0.43 | 2026-08-28 | 10-Q |
| Q2 2026 | 2025-03-31 | -0.27 | 2026-08-28 | 10-Q |
| Q1 2026 | 2024-12-31 | -0.14 | 2026-02-09 | 10-Q |
| FY 2025 | 2024-09-30 | -0.52 | 2025-11-25 | 10-K |
| Q3 2025 | 2024-06-30 | -0.38 | 2025-08-12 | 10-Q |
| Q2 2025 | 2024-03-31 | -0.23 | 2025-05-13 | 10-Q |
| Q1 2025 | 2023-12-31 | -0.11 | 2025-02-12 | 10-Q |
| FY 2025 | 2023-09-30 | -0.60 | 2025-11-25 | 10-K |
| Q3 2024 | 2023-06-30 | -0.47 | 2024-08-06 | 10-Q |
| Q2 2024 | 2023-03-31 | -0.33 | 2024-05-09 | 10-Q |
| Q1 2024 | 2022-12-31 | -0.17 | 2024-02-07 | 10-Q |
| FY 2023 | 2022-09-30 | -0.62 | 2023-11-27 | 10-K |
| FY 2023 | 2021-09-30 | -0.54 | 2023-11-27 | 10-K |
| Q2 2017 | 2017-03-31 | -0.12 | 2017-05-10 | 10-Q |
| Q1 2017 | 2016-12-31 | -0.08 | 2017-02-07 | 10-Q |
| FY 2016 | 2016-09-30 | -0.42 | 2016-12-14 | 10-K |
| Q3 2016 | 2016-06-30 | -0.24 | 2016-08-11 | 10-Q |
| Q2 2017 | 2016-03-31 | -0.17 | 2017-05-10 | 10-Q |
| Q1 2017 | 2015-12-31 | -0.12 | 2017-02-07 | 10-Q |
| FY 2016 | 2015-09-30 | -0.65 | 2016-12-14 | 10-K |
| Q3 2016 | 2015-06-30 | -0.44 | 2016-08-11 | 10-Q |
| Q2 2016 | 2015-03-31 | -0.18 | 2016-05-11 | 10-Q |
| Q1 2016 | 2014-12-31 | -0.06 | 2016-02-08 | 10-Q |
| FY 2016 | 2014-09-30 | -1.02 | 2016-12-14 | 10-K |
| Q3 2015 | 2014-06-30 | -0.04 | 2015-08-14 | 10-Q |
| Q2 2015 | 2014-03-31 | -0.04 | 2015-05-14 | 10-Q |
| Q1 2015 | 2013-12-31 | -0.01 | 2015-02-17 | 10-Q |
| FY 2014 | 2013-09-30 | -0.12 | 2014-12-29 | 10-K |
| Q3 2014 | 2013-06-30 | -0.02 | 2014-08-13 | 10-Q |
| Q2 2013 | 2013-03-31 | -0.02 | 2013-05-17 | 10-Q |
| Q1 2014 | 2012-12-31 | -0.01 | 2014-02-14 | 10-Q |
| FY 2013 | 2012-09-30 | -0.29 | 2013-12-30 | 10-K |
| Q3 2013 | 2012-06-30 | -0.28 | 2013-08-14 | 10-Q |
| Q2 2013 | 2012-03-31 | -0.11 | 2013-05-17 | 10-Q |
| Q1 2013 | 2011-12-31 | -0.08 | 2013-02-14 | 10-Q |
| FY 2012 | 2011-09-30 | -0.29 | 2012-12-31 | 10-K |
| Q3 2012 | 2011-06-30 | -0.24 | 2012-08-17 | 10-Q |
| Q2 2012 | 2011-03-31 | -0.17 | 2012-05-15 | 10-Q |
| Q1 2012 | 2010-12-31 | -0.08 | 2012-02-14 | 10-Q |
| FY 2011 | 2010-09-30 | -0.41 | 2011-12-22 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.